Tested Applications
| Positive WB detected in | K-562 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
18821-1-AP targets LILRA5/CD85f in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
| Calculated Molecular Weight | 299 aa, 33 kDa |
| Observed Molecular Weight | 31-33 kDa |
| GenBank Accession Number | BC153203 |
| Gene Symbol | LILRA5 |
| Gene ID (NCBI) | 353514 |
| RRID | AB_2281279 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | A6NI73 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
LILRA5, also named as CD85f, ILT11, LILRB7 or LIR9, is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is a group of immune inhibitory and stimulatory receptors (PMID: 15304001). There are two membrane-bound and two soluble forms of LILRA5. The transmembrane LILRA5 contains a short cytoplasmic domain and a charged arginine residue within the transmembrane region (PMID: 19009525). It is mostly expressed in myeloid cells, including monocytes and neutrophils (PMID: 12393390). LILRA5 may play a role in triggering innate immune responses. It does not function in class I MHC antigens recognition (PMID: 16675463). The antibody recognizes the isoform 1 and isoform 2 of LILRA5.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for LILRA5/CD85f antibody 18821-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The LILRA5/CD85f Polyclonal antibody (Cat# 18821-1-AP) has 1 citation. It appears in Frontiers in Cellular and Infection Microbiology (IF: 5.5), published in July 2025. The cited study investigates LILRA5+ macrophages and their role in driving early oxidative stress in sepsis using single-cell transcriptomics, placing this antibody within the fields of immunology, infectious disease, and sepsis pathophysiology. The application used was Western blot (WB).
| Species | Application | Title |
|---|---|---|
Front Cell Infect Microbiol LILRA5+ macrophages drive early oxidative stress surge in sepsis: a single-cell transcriptomic landscape with therapeutic implications |



